NuSmile’s NeoMTA provides a bioactive and nontoxic alternative to formocresol without the toxicity concerns associated with formocresol’s formaldehyde component. Nonstaining and radiopaque, it’s also designed to promote dentinal bridging and hydroxyapatite formation, contributing to the tooth’s health and viability.
Unlike hybrid product blends of mineral trioxide aggregate (MTA) and resin, NuSmile says, NeoMTA is designed for maximum effectiveness. According to the company, it also mixes easily to form a putty that’s easy to place and manipulate. The cement’s washout resistance is less than 5 minutes. And, NuSmile says, it sets faster than other MTAs, helping to minimize chair time.
For more information, call (800) 346-5133 or visit nusmile.com.
Related Articles
MTA Proves Cost-Effective in Direct Pulp Capping
Researcher Uses Lasers to Regenerate Dental Tissue
